CE-Ventures

Activity from announced rounds

All recorded activity

CE-Ventures is the venture investment brand named in Think Bioscience and Aptadir financing coverage.

Recorded funding activity

Think Bioscience develops small-molecule drugs for difficult targets. Aptadir develops RNA therapeutics intended to restore expression of silenced genes. Their retained announcements establish the two investment relationships without substituting a parent corporation or an unnamed individual fund.

Sources
Rounds participated in
3
Confirmed lead rounds
0
1 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$160.4M
3 disclosed · full round size, not this investor’s share

By stage

Series A2
Seed1

By primary sector

Biotech3

By country

Italy1
United Kingdom1
United States1

Rounds

3 in all activity
Oyster Therapeutics

Oyster Therapeutics develops protein-degrader medicines for neurodegenerative diseases.

$60MSeries A-2
Participant
Think Bioscience

Develops small molecule drugs for historically challenging drug targets

$55MSeries A
Role not disclosed